1.
Infect Control Hosp Epidemiol
; 39(6): 741-745, 2018 06.
Article
in English
| MEDLINE
| ID: mdl-29606181
ABSTRACT
The use of monthly intranasal mupirocin was associated with a significant reduction in the rate of methicillin-resistant Staphylococcus aureus transmission and Staphylococcus aureus invasive infection in a large neonatal intensive care unit. Resistance to mupirocin emerged over time, but it was rare and was not associated with adverse clinical outcomes.Infect Control Hosp Epidemiol 2018;39:741-745.